In both MVT-1 and MMTV-PyMT tumors (Fig. 2a, b), while RIPK3 levels are very low/undetectable in the early stages of tumor development, RIPK3 expression is dramatically upregulated when tumor reaches certain sizes. This evidence concerns the gene RIPK3 and neoplasm.